Get all your news in one place.
100's of premium titles.
One app.
Start reading
The Economic Times
The Economic Times
Business
Ritesh Presswala

Symbiotec Pharmalab IPO Day 4: GMP at 29%, subscription reaches 5.31x

Symbiotec Pharmalab IPO saw solid demand from investors as the issue ended up getting oversubscribed 71.26 times overall against the 1.31 crore shares available for subscription by the final day of subscription, showed NSE data.

The IPO has been subscribed 5.31 times overall against the 1.31 crore shares on offer. The retail portion has been subscribed 5.05 times, against 65.44 lakh shares reserved for retail investors.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.